HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of Wegener granulomatosis after treatment for non-tuberculous mycobacteriosis].

Abstract
A 67-year-old woman with a history of non-tuberculous mycobacteriosis due to Mycobacterium avium in 2002 and 2006 was admitted because of low-grade fever and cavitary lesions in both lungs on chest computed tomography (CT). Bronchial brushing cytology by bronchoscopy did not yield mycobacterium. Her serum antineutrophil cytoplasmic antibodies (MPO-ANCA) level was elevated and PR3 ANCA was negative. A surgical lung biopsy revealed basophilic necrosis with cavitary lesions and necrotizing vasculitis compatible with Wegener granulomatosis (WG). In the resected specimen, several hyalinizing nodules with caseous necrosis, probably associated with previous mycobacterium infection, were also seen. Because her disease was limited to the lungs, we successfully treated her with corticosteroids and methotrexate. WG is considered to be a type of ANCA-associated vasculitis, and microbial infections have been associated with initiation and relapse of WG. This case clearly demonstrated that lesions of WG occurred after mycobacterial infection in the lung. We believe that this case was ANCA production in association with bacterial infection.
AuthorsMunehisa Fukusumi, Kenji Miyazaki, Masahiko Shibata, Toyoaki Aizawa, Toshihiko Sakai, Tamiko Takemura, Hirokazu Tojima
JournalNihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society (Nihon Kokyuki Gakkai Zasshi) Vol. 49 Issue 1 Pg. 37-43 (Jan 2011) ISSN: 1343-3490 [Print] Japan
PMID21384680 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
Topics
  • Aged
  • Antibodies, Antineutrophil Cytoplasmic (blood)
  • Female
  • Granulomatosis with Polyangiitis (etiology, immunology)
  • Humans
  • Mycobacterium avium-intracellulare Infection (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: